Corporate Information | Press & Media | For Investors

ThinkGenetic

ThinkGenetic

Finding Patients At Risk for Rare Disease

  • Home
  • Solutions
    • FindEHR™
    • FindSM™
  • Research
    • Medical Publications
    • Technical Research
  • About
    • Team
    • Board
    • Partners
  • News & Events
  • Contact
  • Request a Demo

[Press Release] Guardian Research Network and ThinkGenetic Announce Collaborative Partnership to Accelerate Diagnosis and Treatment Options for Patients with Genetic Diseases and Inherited Predisposition to Cancer

July 28, 2022 by Ruth O'Keefe

 Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.

News, Partners, Press Releases algorithm, announcement, Bruce Braughton, Dave Jacob, diagnostic odyssey, digital health, EHR, electronic health records, genetic condition, genetic disease, GRN, Guardian Research Network, healthcare, Mark Watson, partnership, press release, PTC Therapeutics, Rare Disease, ThinkGenetic

[Press Release] Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients

April 20, 2021 by Ruth O'Keefe

ThinkGenetic, Inc. announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund.

Investor News, News, Press Releases artificial intelligence, Dave Jacob, genetic disease, Healthcare Innovation Fund, Lafayette, Lafayette General Health Systems, machine learning, Ochsner, Ochsner Lafayette General, Rare Disease, SymptomMatcher, ThinkGenetic

[Press Release] ThinkGenetic Announces Integration of Innovative Diagnostic Aid in Takeda Pilot Awareness Initiative

December 15, 2020 by Ruth O'Keefe

ThinkGenetic, Inc. is set to launch three disease-specific versions of the diagnostic aid, SymptomMatcher™ for upcoming pilot awareness initiatives by global biopharmaceutical leader, Takeda Pharmaceutical Company Limited.

Investor News, News, Press Releases Fabry disease, Gaucher disease, genetic disease, Hunter syndrome, MPS II, partnership, pilot, Shire, Takeda, ThinkGenetic

[Press Release] ThinkGenetic Closes $1.5M Angel Round of Funding

February 19, 2019 by Ruth O'Keefe

ThinkGenetic, Inc., makers of an artificial intelligence-driven SymptomMatcher™​ for genetic disorders, today announced the successful close of its angel round of funding for $1.5M.

Investor News, News, Partners, Press Releases Acadiana, AccelerateSouth, Billy Tauzin, Cian Robinson, clinicial trials, Dave Jacob, genetic disease, Innovation, Lafayette, Lafayette General Health, Lafayette General Health System, LFHS, Louisiana, Research and Real Estate Investments, ThinkGenetic

Could a Biological Trojan Horse Help Us Cure Genetic Diseases?

August 8, 2018 by Morgan Simmons, MMSc, CGC

Most medical treatments fall into four broad categories based on their goal: For the most part, treatments for genetic diseases have fallen into the preventive, disease management, or palliative categories. […]

Education clinical trials, disease management, DNA, gene therapy, genes, genetic condition, genetic counseling, genetic counselor, genetic disease, genetic disorder, genetic testing, germ line cells, inherited condition, Morgan Simmons, personalized medicine, Rare Disease, somatic cells, treatment genetic disease

Upcoming Events

  • There are no upcoming events.

Together let’s systematically accelerate detecting at-risk  individuals.

Request a Demo

  • Solutions
    • FindEHR™
    • FindSM™
  • Resources
    • Contact
    • Research
    • FAQs
  • About ThinkGenetic
    • Team
    • Board
    • Investors
    • Careers
  • Legal
    • Disclaimers
    • Privacy Policy

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

ThinkGenetic does not provide medical advice, diagnosis or treatment. Click here for more information.

©2023 ThinkGenetic. All Rights Reserved.